Research analysts at Bank of America assumed coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) in a research report issued on Monday, MarketBeat.com reports. The firm set a “buy” rating and a $29.00 price target on the biotechnology company’s stock. Bank of America‘s price target would suggest a potential upside of 23.77% […]

Ossiam raised its holdings in shares of Arrow Electronics, Inc. (NYSE:ARW – Free Report) by 121.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 933 shares of the technology company’s stock after acquiring an additional 511 shares during the quarter. Ossiam’s holdings […]